Banque Cantonale Vaudoise’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-1,000
| Closed | -$23K | – | 752 |
|
2024
Q2 | $23K | Hold |
1,000
| – | – | ﹤0.01% | 861 |
|
2024
Q1 | $25K | Hold |
1,000
| – | – | ﹤0.01% | 852 |
|
2023
Q4 | $23K | Hold |
1,000
| – | – | ﹤0.01% | 876 |
|
2023
Q3 | $51K | Hold |
1,000
| – | – | ﹤0.01% | 962 |
|
2023
Q2 | $47K | Hold |
1,000
| – | – | ﹤0.01% | 970 |
|
2023
Q1 | $38K | Hold |
1,000
| – | – | ﹤0.01% | 993 |
|
2022
Q4 | $55K | Hold |
1,000
| – | – | ﹤0.01% | 937 |
|
2022
Q3 | $34K | Hold |
1,000
| – | – | ﹤0.01% | 1040 |
|
2022
Q2 | $9K | Hold |
1,000
| – | – | ﹤0.01% | 1176 |
|
2022
Q1 | $14K | Hold |
1,000
| – | – | ﹤0.01% | 1168 |
|
2021
Q4 | $21K | Hold |
1,000
| – | – | ﹤0.01% | 1164 |
|
2021
Q3 | $22K | Hold |
1,000
| – | – | ﹤0.01% | 1132 |
|
2021
Q2 | $25K | Hold |
1,000
| – | – | ﹤0.01% | 1127 |
|
2021
Q1 | $29K | Buy |
+1,000
| New | +$29K | ﹤0.01% | 1028 |
|